Table 1 Baseline characteristics for the study population.

From: Efficacy and safety of outpatient fludarabine, cyclophosphamide, and rituximab based allogeneic hematopoietic cell transplantation in adults with severe aplastic anemia

Baseline Characteristic

Patients (N = 24)

Median duration of follow-up, days (range)

807 (72–2180)

Age at time of Transplant, median (IQR)

43.5 (33–52)

Female sex, no. (%)

10 (42)

White race, no. (%)

20 (83)

Median Charlson Comorbidity Index, score (range)

0 (0–5)

Median prior lines of therapy, no. (range)

1.5 (1–5)

Donor type, no. (%)

• Haploidentical

2 (8)

• Matched related donor

8 (33)

• Matched unrelated donor

14 (58)

Stem cell source, no. (%)

• Bone marrow

9 (38)

• Peripheral blood

15 (62)